Fresh analysis suggests that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional lifestyle plans.
Research printed in a prominent medical journal demonstrates that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing such medications should be aware of the potential of quick weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass in about one and a half years.
Weighing Treatments
The analysis, which examined dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with other pills.
Scientists emphasize that people who lose weight through dieting usually experience a more gradual weight regain—around 100 grams monthly—once they finish.
Explaining the Fast Regain
Doctors believe the mode of action of the injections is key to understanding the accelerated rebound.
These medications imitate a natural hormone called GLP-1, which moderates hunger.
"Artificially providing the hormone concentrations far above than normal may cause the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating much more probable."
A Chronic Issue?
Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians argue that, given the high risk of relapse, the therapy is often life-long.
This opinion is reinforced by drug manufacturers, who note that the findings "highlight the persistent character of excess weight," similar to managing conditions like high blood pressure.
Patient Experiences
Individuals who have come off the jabs report a intense return of appetite.
"I experienced something that goes on and you become extremely hungry," said one woman.
This challenge is exacerbated if individuals have not established sustainable dietary or behavioural modifications during therapy.
Growing Interest
Figures suggest that millions of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Use is more common among females compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while GLP-1 drugs are effective tools for weight loss, they are not a magic fix and lasting health benefits likely depends on combined lifestyle management.
